Since metastatic spread of CRC to the peritoneal cavity is common and difficult to treat, the study focused on intraperitoneal delivery of CEA-targeted CAR-T cells as a mode of localized delivery. This evidence concerns the gene CEACAM5 and colorectal carcinoma.